The purpose of this registry is to evaluate the situation regarding ambulant therapy of cancer patients in different practices in Germany. It should provide insight into the implementation of schemes for cancer therapy predefined in the guidelines, the treatment of diverse adverse reactions and the counter measures taken. Thereby, potential differences in treatment and with that differences in quality amongst individual practices might be identified. The medium to long term aim is to contribute to positively influence the quality of medical care of cancer patients in Germany.
Study Type
OBSERVATIONAL
Enrollment
2,000
Practice
Mannheim, Germany
RECRUITINGAnti-cancer treatments (Course of the disease and type of applied anti-cancer therapies. Assessment of guidelines' implementation)
Course of the disease and type of applied anti-cancer therapies. Assessment of guidelines' implementation
Time frame: From date of ICF until date of cure/death/ICF withdrawal, up to 60 months
Adverse reactions and their treatment (Number and type of adverse reactions and applied counter measures / therapies)
Number and type of adverse reactions and applied counter measures / therapies
Time frame: From date of ICF until date of cure/death/ICF withdrawal, up to 60 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.